08/03
Headlines

CNAT

Investors Are Watching : Time Warner Inc. (NYSE:TWX), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Allegheny Technologies Inc. (NYSE:ATI), ArQule Inc. (NASDAQ:ARQL), USMD Holdings, Inc. (NASDAQ:USMD)

John Bellich03 mins

Time Warner Inc. (NYSE:TWX) cut its ties to Time Inc., the once-great magazine publisher. The Tribune Company, keeping its television stations, has created a separately traded entity called Tribune Publishing for its newspapers. News Corp. now holds Rupert Murdoch’s newspapers, while 21st Century Fox has his entertainment properties. E. W. Scripps sent its papers packing….

Read More

Trader’s Recap : Emergent BioSolutions (NYSE:EBS), Conatus Pharmaceuticals (NASDAQ:CNAT), Cabot Microelectronics (NASDAQ:CCMP), MakeMyTrip (NASDAQ:MMYT), Vision-Sciences Inc. (NASDAQ:VSCI)

Chris Lewis02 mins

Emergent BioSolutions Inc. (NYSE:EBS) announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration (FDA) for Anthrax Immune Globulin Intravenous (Human) [AIGIV] as part of a development contract with the Biomedical Advanced Research and Development Authority (BARDA). AIGIV, which was acquired in the Cangene acquisition completed earlier this year,…

Read More

Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

Mark DeFrance02 mins

A Palo Alto startup will focus an $18 million VC investment on developing a drug to stop unexplained recurrent miscarriages. Nora Therapeutics is capitalizing on work started by cofounder Darryl Carter at Johns Hopkins University that led to development of Nora’s lead drug, NT-100. Nora is led by CEO Jeff Tong, who had been vice…

Read More

Biotech Bearish Stocks: Conatus Pharmaceuticals Inc (NASDAQ:CNAT), Kindred Biosciences (NASDAQ:KIN), BIND Therapeutics (NASDAQ:BIND), Aratana Therapeutics (NASDAQ:PETX)

Kristen Barton02 mins

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) was the recipient of a large growth in short interest in January. As of March 14th, there was short interest totalling 985,400 shares, a growth of 82.6% from the February 28th total of 539,790 shares, Analyst Ratings News reports. Conatus Pharmaceuticals Inc (NASDAQ:CNAT) stock performance was -6.33% in last session and…

Read More

Bearish Stocks at NASDAQ: Conatus Pharmaceuticals (NASDAQ:CNAT), Metabolix (NASDAQ:MBLX), Clovis Oncology (NASDAQ:CLVS), Oculus Innovative Sciences (NASDAQ:OCLS)

Richard Atkins02 mins

On March 27, 2014, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) issued a press release announcing its financial results for the quarter and year ended December 31, 2013. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) stock performance was -15.63% in last session and finished the day at $8.42. Traded volume was 1.28 million shares in the last session and the average…

Read More

Microcap Gainers: BG Medicine (NASDAQ:BGMD), AirMedia Group (NASDAQ:AMCN), Conatus Pharmaceuticals (NASDAQ:CNAT), Highpower International Inc (NASDAQ:HPJ)

Jason Knox02 mins

BG Medicine, Inc. (NASDAQ:BGMD) announced today the publication of results, in the American Heart Journal, of an analysis of aggregated data from three large, multicenter clinical research trials in the United States and Europe. BG Medicine, Inc. (NASDAQ:BGMD) stock performance was 22.35% in last session and finished the day at $2.08. Traded volume was 17.57million…

Read More